Top Institutional Investors

ARMISTICE CAPITAL, LLC — 13F Holdings & Portfolio

CIK 1601086 · latest 13F-HR filed 2026-08-14

Backtest portfolio

ARMISTICE CAPITAL, LLC manages $8.17B in 13F-reported U.S. long-equity assets across 341 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SPY (22.84%), IWM (17.64%), SPY (6.40%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 169 new positions, exited 97, added to 88, and trimmed 52.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Filer Information
Address
510 MADISON AVENUE, 7TH FLOOR
NEW YORK, NY 10022
Phone
(212) 231-4932
Filing Manager
ARMISTICE CAPITAL, LLC
NEW YORK, NY
Signatory
Anthony Cordone
Chief Financial Officer
Loading holdings…
AUM

$8.17B

Long-equity book

Holdings

341

Distinct positions

Period

2026-06-30

Filed 2026-08-14

Q/Q Activity

+169 / −97 / ↑88 / ↓52

vs 2026-03-31

Firm Profile & Key People
Name Title / Status Ownership Type

Top Adds (vs prior quarter)

  • CYTOKINETICS INC$52.0M +103.1%
  • INCYTE CORP$40.2M +65.0%
  • UNITEDHEALTH GROUP INC$36.0M +89.9%
  • SANOFI SA$30.9M +214.0%
  • RIGEL PHARMACEUTICALS INC$30.8M +89.0%
Show all 88 →

Top Trims

  • TRAVERE THERAPEUTICS INC-$56.2M -38.6%
  • PTC THERAPEUTICS INC-$53.9M -38.2%
  • IMMUNOVANT INC-$21.7M -24.5%
  • DATADOG INC-$14.8M -60.2%
  • ALIBABA GROUP HLDG LTD-$9.5M -37.0%
Show all 52 →

New Positions

  • WATERS CORP$28.1M
  • ILLUMINA INC$16.0M
  • PRESTIGE CONSMR HEALTHCARE I$15.9M
  • LIBERTY MEDIA CORP DEL$15.7M
  • INTEGER HLDGS CORP$15.7M
Show all 169 →

Exited Positions

  • AVANOS MED INC$28.0M
  • MEDLINE INC$25.1M
  • KALVISTA PHARMACEUTICALS INC$24.9M
  • ENERGIZER HLDGS INC$19.7M
  • META PLATFORMS INC$18.6M
Show all 97 →
All Holdings

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 STATE STR SPDR S&P 500 ETF T Put SPY 78462F103 $1.87B 22.84% 2,500,000 SH
2 ISHARES TR Put IWM 464287655 $1.44B 17.64% 4,800,000 SH
3 STATE STR SPDR S&P 500 ETF T Put SPY 78462F103 $522.7M 6.40% 700,000 SH
4 ISHARES TR Put IWM 464287655 $300.4M 3.68% 1,000,000 SH
5 SUPERNUS PHARMACEUTICALS SUPN 868459108 $123.1M 1.51% 2,646,201 SH
6 CYTOKINETICS INC Call CYTK 23282W605 $106.5M 1.30% 1,250,000 SH
7 AGIOS PHARMACEUTICALS INC Call AGIO 00847X104 $104.3M 1.28% 2,810,000 SH
8 CYTOKINETICS INC CYTK 23282W605 $102.3M 1.25% 1,201,342 SH
9 INCYTE CORP INCY 45337C102 $102.0M 1.25% 900,005 SH
10 NEUROCRINE BIOSCIENCES INC NBIX 64125C109 $90.3M 1.10% 535,838 SH
11 TRAVERE THERAPEUTICS INC TVTX 89422G107 $89.3M 1.09% 1,572,539 SH
12 AGIOS PHARMACEUTICALS INC AGIO 00847X104 $89.1M 1.09% 2,400,000 SH
13 PTC THERAPEUTICS INC PTCT 69366J200 $87.4M 1.07% 1,071,395 SH
14 UNITEDHEALTH GROUP INC UNH 91324P102 $76.1M 0.93% 183,000 SH
15 FRESHPET INC FRPT 358039105 $74.5M 0.91% 1,260,702 SH
16 DYNE THERAPEUTICS INC DYN 26818M108 $68.6M 0.84% 3,087,226 SH
17 AMAZON COM INC AMZN 023135106 $67.8M 0.83% 284,562 SH
18 IMMUNOVANT INC IMVT 45258J102 $66.9M 0.82% 1,736,000 SH
19 RIGEL PHARMACEUTICALS INC RIGL 766559702 $65.4M 0.80% 1,672,000 SH
20 THERMO FISHER SCIENTIFIC INC TMO 883556102 $61.4M 0.75% 122,480 SH
21 IRONWOOD PHARMACEUTICALS INC IRWD 46333X108 $58.7M 0.72% 13,932,000 SH
22 MADRIGAL PHARMACEUTICALS INC MDGL 558868105 $58.0M 0.71% 108,000 SH
23 HARMONY BIOSCIENCES HLDGS IN HRMY 413197104 $56.9M 0.70% 1,564,000 SH
24 REGENERON PHARMACEUTICALS REGN 75886F107 $56.0M 0.69% 89,809 SH
25 MADRIGAL PHARMACEUTICALS INC MDGL 558868105 $53.7M 0.66% 100,000 SH
26 NEKTAR THERAPEUTICS NKTR 640268306 $50.5M 0.62% 724,000 SH
27 MINERALYS THERAPEUTICS INC MLYS 603170101 $46.8M 0.57% 1,736,000 SH
28 SANOFI SA SNY 80105N105 $45.4M 0.56% 1,064,000 SH
29 IMMUNOCORE HLDGS PLC IMCR 45258D105 $45.3M 0.55% 1,428,000 SH
30 ALPHABET INC GOOGL 02079K305 $45.2M 0.55% 126,494 SH
31 MADRIGAL PHARMACEUTICALS INC MDGL 558868105 $43.0M 0.53% 80,000 SH
32 SOLID BIOSCIENCES INC SLDB 83422E204 $42.7M 0.52% 4,278,000 SH
33 MONGODB INC MDB 60937P106 $42.0M 0.51% 125,172 SH
34 KURA ONCOLOGY INC KURA 50127T109 $40.3M 0.49% 3,678,000 SH
35 DENTSPLY SIRONA INC XRAY 24906P109 $39.0M 0.48% 3,672,000 SH
36 UBER TECHNOLOGIES INC UBER 90353T100 $35.9M 0.44% 497,908 SH
37 AXOGEN INC AXGN 05463X106 $35.8M 0.44% 775,000 SH
38 DISC MEDICINE INC IRON 254604101 $33.6M 0.41% 460,000 SH
39 GITLAB INC GTLB 37637K108 $32.8M 0.40% 1,074,141 SH
40 FIVE9 INC FIVN 338307101 $32.7M 0.40% 1,536,000 SH
41 HUBSPOT INC HUBS 443573100 $32.5M 0.40% 178,047 SH
42 ALIGN TECHNOLOGY INC ALGN 016255101 $30.4M 0.37% 180,286 SH
43 MICROSOFT CORP MSFT 594918104 $30.1M 0.37% 80,581 SH
44 ORTHOFIX MED INC OFIX 68752M108 $29.8M 0.36% 3,264,000 SH
45 PTC THERAPEUTICS INC Call PTCT 69366J200 $29.4M 0.36% 360,000 SH
46 HUMANA INC HUM 444859102 $28.8M 0.35% 72,527 SH
47 ANGIODYNAMICS INC ANGO 03475V101 $28.6M 0.35% 2,198,000 SH
48 TRAVERE THERAPEUTICS INC Call TVTX 89422G107 $28.4M 0.35% 500,000 SH
49 WATERS CORP WAT 941848103 $28.1M 0.34% 75,004 SH
50 MINERALYS THERAPEUTICS INC Call MLYS 603170101 $28.1M 0.34% 1,040,000 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $8.17B 341 0001315863-26-000589
2026-03-31 2026-05-15 $5.62B 267 0001315863-26-000414
2025-12-31 2026-02-17 $8.40B 370 0001315863-26-000163
2025-09-30 2025-11-17 $6.74B 332 0001315863-25-000814